Bloomington, Ind. – Cook Medical applauds the FDA’s efforts to protect women’s health by continuing to investigate the issues surrounding the use of surgical mesh for the treatment of pelvic floor disorders. We commend the FDA’s support of open scientific discussion of the effectiveness of transvaginal surgical mesh placement for pelvic organ prolapse and stress urinary incontinence repair.
We have long been aware of the risks associated with the use of permanent materials to repair the pelvic floor. Because patient interest is our foremost concern, we have partnered with physicians and have developed alternative procedures and advanced materials that are present only during the healing process to help mitigate the concerns of mesh erosions.
We welcome the development of an open forum to discuss the scientific and clinical issues that relate to this topic.This forum will enable open scientific discussion of the risks and potential benefits to patients who suffer with disorders of the pelvic floor.
Cook Medical will continue our work with clinicians to identify best practices and support the continued evolution of techniques and materials for pelvic floor restoration.
About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologics to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation.
For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter at @CookMedicalPR or @CookSurgery.